REUNION NEUROSCIENCE

Reunion Neuroscience is a clinical stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions... Our research is centered on the discovery and development of proprietary drug candidates designed to engage serotonergic receptors in the brain. By targeting this key pathway, Reunion aims to induce therapeutically beneficial changes in a variety of psychiatric conditions, including depression... Reunion envisions a day when depression isn't just managed, it's curable. That's why we relentlessly pursue the development of safer and more accessible therapeutics. As an early-stage pharmaceutical company, we're focused on pushing the boundaries of neuroscience to develop new and improved options for the millions of people whose needs are not met by the current standard of care.

Also known as: Reunion Neuroscience, Inc.

Primary location: Philadelphia United States